Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 800 of 1463 entries
View as:

Lenvatinib vs Bevacizumab Plus ICIs and HAIC in Unresectable HCC

Phase: N/A Priority: Normal
NCT ID: NCT06435013 Org: User:
Start: 12/01/23 End: 05/20/24 Due: 05/20/25

The New Serial Treatment of Temporomandibular Disorders

Phase: N/A Priority: Normal
NCT ID: NCT00932594 Org: User:
Start: 01/31/06 End: 12/31/26 Due: 12/31/27

Biomarkers of Common Eye Diseases

Phase: N/A Priority: Normal
NCT ID: NCT04101604 Org: User:
Start: 09/26/19 End: 10/01/21 Due: 10/01/22

Flexible Colonoscope Assisted Hybrid Transanal Total Mesorectal Resection (taTME)

Phase: N/A Priority: Normal
NCT ID: NCT06380855 Org: User:
Start: 08/24/22 End: 08/24/25 Due: 08/24/26

A Retrospective Cohort Study: Influence of MTHFR C677T and A1298C Polymorphisms on the Survival of Pediatric Patients With Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04469543 Org: User:
Start: 01/20/14 End: 05/20/20 Due: 05/20/21

Validation of the Utility of Myopia Intelligent Diagnostic System

Phase: N/A Priority: Normal
NCT ID: NCT04014725 Org: User:
Start: 07/10/19 End: 08/01/19 Due: 08/01/20

577nm Micropulse Laser vs Half-dose Photodynamic Therapy on Acute Central Serous Chorioretinopathy

Phase: N/A Priority: Normal
NCT ID: NCT02587767 Org: User:
Start: 09/30/16 End: 12/31/19 Due: 12/31/20

Toripalimab Plus Etoposide and Platinum-based Chemotherapy for Genitourinary Small Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05760053 Org: User:
Start: 02/18/23 End: 02/18/26 Due: 02/18/27

Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04333927 Org: User:
Start: 06/01/20 End: 06/30/24 Due: 06/30/25

Conservative Versus Aggressive Discectomy for Primary Disc Herniation With Radiculopathy

Phase: N/A Priority: Normal
NCT ID: NCT01204008 Org: User:
Start: 09/30/09 End: 12/31/15 Due: 12/31/16

A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC

Phase: N/A Priority: Normal
NCT ID: NCT03303495 Org: User:
Start: 11/14/11 End: 12/31/18 Due: 12/31/19

Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01147627 Org: User:
Start: 08/31/10 End: 12/31/12 Due: 12/31/13

Using Machine Learning to Adapt Visual Aids for Patients With Low Vision

Phase: N/A Priority: Normal
NCT ID: NCT04892316 Org: User:
Start: 07/27/20 End: 12/27/21 Due: 12/27/22

A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative Resection

Phase: N/A Priority: Normal
NCT ID: NCT04392700 Org: User:
Start: 07/25/19 End: 07/25/24 Due: 07/25/25

Concurrent Nab-paclitaxel with Intensity-modulated Radiation Therapy in Patients with Stage III-IVa Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06611150 Org: User:
Start: 08/02/24 End: 08/01/27 Due: 08/01/28

Impacts of PIO/MET Following Short-term Intensive Insulin Treatment in Newly Diagnosed Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03196362 Org: User:
Start: 12/01/16 End: 12/31/18 Due: 12/31/19

AK112 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI as Second-line Treatment of MSS/pMMR Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT07021950 Org: User:
Start: 08/10/25 End: 12/31/28 Due: 12/31/29

Routine Therapy Plus Moxifloxacin in Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03405168 Org: User:
Start: 01/01/18 End: 07/30/18 Due: 07/30/19

Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain

Phase: N/A Priority: Normal
NCT ID: NCT05304468 Org: User:
Start: 05/11/22 End: 10/29/29 Due: 10/29/30

Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC

Phase: N/A Priority: Normal
NCT ID: NCT04544969 Org: User:
Start: 04/01/20 End: 12/31/27 Due: 12/31/28

Phase II Study of TAEST16001 in Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT05549921 Org: User:
Start: 07/08/22 End: 09/01/24 Due: 09/01/25

A Study of Gefitinib With or Without Apatinib in Patients With Advanced Non-squamous Non-Small-Cell Lung Cancer Harboring EGFR Mutations

Phase: N/A Priority: Normal
NCT ID: NCT02824458 Org: User:
Start: 06/30/16 End: 12/31/23 Due: 12/31/24

Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02396043 Org: User:
Start: 03/31/15 End: 03/31/25 Due: 03/31/26

PD-1 Blockade Combined With De-intensified Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04907370 Org: User:
Start: 08/01/21 End: 03/01/27 Due: 03/01/28

A TTM-based Smoking Cessation Intervention in Helping Expectant Fathers to Quit Smoking and Maintain Abstinence

Phase: N/A Priority: Normal
NCT ID: NCT06663475 Org: User:
Start: 11/04/24 End: 12/31/26 Due: 12/31/27